Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells
- PMID: 16341141
- DOI: 10.1038/sj.cgt.7700923
Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells
Abstract
E1B55K-deleted dl1520 could selectively replicate in cancer cells and has been used in clinical trials as an antitumor agent. The mechanism of virus selective replication in cancer cells, including a possible role of p53, is unclear. Studies with established cancer cell lines have demonstrated that some cancer cells are resistant to dl1520 replication, regardless of the p53 status. Hep3B cells supported the E1b-deleted adenoviruses to replicate, whereas Saos2 cells were resistant to viral replication. We applied p53-null Hep3B and Saos2 cells as models to clarify the replication ability of E1B55K-deleted adenoviruses with different expression levels of E1a. We show that lower E1A expression in Saos2 may be the reason for the poor replication in some cancer cells due to the fact that E1a promoter was less activated in Saos2 than in Hep3B. We also demonstrate that the E1B55K protein can increase E1A expression in Saos2 cells for efficient virus replication. In addition, the upstream regions of the E1a promoter have transcriptional activity in Hep3B cells but not in Saos2 cells. The viral E1B55K protein may activate cancer cellular factor(s) that targets the upstream regions of the E1a gene to increase its expression. This is the first study demonstrating that E1B55K protein affects the E1A production levels that is related to cancer selective replication. Our studies have suggested that increase of E1A expression from E1b-deleted adenoviruses may enhance killing cancer cells that otherwise are resistant to viral replication.
Similar articles
-
An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.Cancer Res. 2003 Apr 1;63(7):1490-9. Cancer Res. 2003. PMID: 12670895
-
Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.J Gene Med. 2006 Jun;8(6):679-89. doi: 10.1002/jgm.904. J Gene Med. 2006. PMID: 16570242
-
Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses.J Virol. 2005 May;79(9):5455-65. doi: 10.1128/JVI.79.9.5455-5465.2005. J Virol. 2005. PMID: 15827160 Free PMC article.
-
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?Gene Ther. 2001 Jan;8(2):89-98. doi: 10.1038/sj.gt.3301377. Gene Ther. 2001. PMID: 11313778 Review.
-
Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.Oncogene. 2000 Dec 27;19(56):6660-9. doi: 10.1038/sj.onc.1204094. Oncogene. 2000. PMID: 11426652 Review.
Cited by
-
Development of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer Selection.Viruses. 2016 Jun 14;8(6):167. doi: 10.3390/v8060167. Viruses. 2016. PMID: 27314377 Free PMC article.
-
The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy.Cancer Biol Ther. 2018;19(12):1174-1184. doi: 10.1080/15384047.2018.1491503. Epub 2018 Aug 1. Cancer Biol Ther. 2018. PMID: 30067431 Free PMC article.
-
Adenovirus with DNA Packaging Gene Mutations Increased Virus Release.Viruses. 2016 Dec 20;8(12):333. doi: 10.3390/v8120333. Viruses. 2016. PMID: 27999391 Free PMC article.
-
Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter.J Mol Med (Berl). 2015 Feb;93(2):211-23. doi: 10.1007/s00109-014-1214-6. Epub 2014 Nov 8. J Mol Med (Berl). 2015. PMID: 25376708 Free PMC article.
-
Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma.Cancer Gene Ther. 2010 Nov;17(11):803-13. doi: 10.1038/cgt.2010.37. Epub 2010 Aug 6. Cancer Gene Ther. 2010. PMID: 20689571 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous